Bionomics Limited Files 8-K

Ticker: NEUP · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1191070

Bionomics Limited/Fi 8-K Filing Summary
FieldDetail
CompanyBionomics Limited/Fi (NEUP)
Form Type8-K
Filed DateDec 16, 2024
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, regulatory-update

TL;DR

Bionomics filed an 8-K on 12/16/24, check for updates.

AI Summary

Bionomics Limited filed an 8-K on December 16, 2024, reporting other events and financial statements/exhibits. The filing does not contain specific details about the nature of these events or financial figures within the provided text.

Why It Matters

This filing indicates that Bionomics Limited has made a regulatory submission to the SEC, which may contain important updates for investors.

Risk Assessment

Risk Level: low — The filing is a routine regulatory submission without immediate disclosed financial impact or significant corporate changes.

Key Players & Entities

  • BIONOMICS LIMITED (company) — Registrant
  • December 16, 2024 (date) — Date of earliest event reported
  • 200 Greenhill Road Eastwood, SA Australia 5063 (address) — Principal executive offices

FAQ

What specific events are being reported in this 8-K filing?

The provided text indicates the filing is for 'Other Events' and 'Financial Statements and Exhibits' but does not specify the details of these events.

When was the earliest event reported in this filing?

The earliest event reported was on December 16, 2024.

What is the principal executive office address for Bionomics Limited?

The principal executive office is located at 200 Greenhill Road Eastwood, SA Australia 5063.

What is the SEC file number for Bionomics Limited?

The SEC file number is 001-41157.

What is the SIC code for Bionomics Limited?

The Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 584 words · 2 min read · ~2 pages · Grade level 12.7 · Accepted 2024-12-16 16:46:50

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. BIONOMICS LIMITED Date: December 16, 2024 By: /s/ Spyridon Papapetropoulos Spyridon Papapetropoulos President and Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.